CompletedNot Applicable

HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women

United States10 participantsStarted 2017-02-02

Plain-language summary

The proposed study will examine the implementation of a Human Papilloma Virus (HPV) self-sampling intervention for under screened LBQ women living in South Florida. The study will enroll participants to receive the self-sampling intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.

Who can participate

Age range25 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-identify as lesbian, bisexual, or queer woman * Assigned female sex at birth * English speaking * ages 25-65 years * report not having had a pap smear in the last three years (per USPSTF guidelines) * if age 30 or over, report not having a pap smear/HPV co-test within the past 5 years (per USPSTF guidelines) Exclusion Criteria: * report having had a hysterectomy * report having history of cervical cancer * unable to consent * Pregnant women * Prisoners

What they're measuring

HPV Self-sampling uptake

Timeframe: through study completion, up to 1 year

Trial details

NCT IDNCT03012932

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03-24

View on ClinicalTrials.gov More Cervical Cancer Screening trials